Cargando...
Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic
Deprescribing aims to reduce polypharmacy, especially in the elderly population, in order to maintain or improve quality of life, reduce harm from medications, and limit healthcare expenditure. Coronavirus disease (COVID-19) is an infectious disease that has led to a pandemic and has changed the liv...
Guardado en:
| Publicado en: | Res Social Adm Pharm |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7256521/ https://ncbi.nlm.nih.gov/pubmed/32499161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sapharm.2020.05.025 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|